NCT05677256View on ClinicalTrials.gov

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

August 25, 2024

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

nOPV2

Vaccination

Trial Locations (1)

1212

International Centre for Diarrhoeal Diseases Research, Dhaka

Sponsors

Lead Sponsor

Fidec Corporation
All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Fidec Corporation

OTHER

NCT05677256 - A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 | Biotech Hunter | Biotech Hunter